Literature DB >> 28485354

Detailed study of survival of patients with renal cell carcinoma in India.

G P Abraham1, T Cherian1, P Mahadevan1, T S Avinash1, D George1, E Manuel1.   

Abstract

PURPOSE: Renal cell carcinoma (RCC) accounts for approximately 90% of all renal malignancies. The rates of kidney cancers are high in developed countries and low in eastern countries and Africa. The objective was to conduct a survival study among Indian population following nephrectomy for RCC as there was a paucity of Indian studies in medical literature.
MATERIALS AND METHODS: We conducted a follow-up study of eighty RCC patients who had nephrectomy between January 2003 and December 2010. These patients had pathological diagnosis after nephrectomy. The follow-up was done up to December 2015. The survival statistics were compiled according to Kaplan-Meier survival curves.
RESULTS: The overall survival of eighty patients was 77%. The patients with tumor size ≤7 cm and the patients with tumor size> 7 cm showed significant statistical difference at 5-year survival (P < 0.0001). The patients with low nuclear grade (1 and 2) and the patients with high nuclear grade (3 and 4) showed significant statistical difference at 5-year survival (P < 0.0001). The patients with tumor node metastasis stage below T3 and the patients with clinical stage above or equal to T3 showed significant statistical difference at 5-year survival (P = 0.003).
CONCLUSION: This study has demonstrated the importance of factors such as tumor size, nuclear grade, and stage in the assessment of prognosis of RCC patients. More studies in India with more patients are needed to demonstrate the importance of these prognostic factors.

Entities:  

Mesh:

Year:  2016        PMID: 28485354     DOI: 10.4103/0019-509X.204758

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  3 in total

1.  Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature.

Authors:  Pooja Dalakoti; Kailesh Pujary; Balakrishnan Ramaswamy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-24

2.  Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour.

Authors:  Sandeep Kondisetty; Krishnakumar N Menon; Ginil Kumar Pooleri
Journal:  Biomark Res       Date:  2018-07-11

3.  Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma.

Authors:  Deepika Chandrasekaran; Sandhya Sundaram; Kadhiresan N; Padmavathi R
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.